EN
Anesthesia management in a pregnant patient with neurofibromatosis
Abstract
Neurofibromatosis (NF) is a genetic and multisystemic disease with autosomal dominant transition. It can affect anesthesia applications by affecting more than one system. In the presence of neurofibromas in the airway, it can cause airway obstruction and difficulties in respiratory delivery during general anesthesia. The presence of tumors affecting the central nervous system makes spinal anesthesia risky. Anesthesiologists should act with awareness of each multisystemic complication when evaluating and managing patients. This case report aims to present our general anesthesia practice in an elective cesarean operation in a pregnant patient with neurofibromatosis type 1.
Keywords
Kaynakça
- 1. Fox CJ, Tomajian S, Kaye AJ, Russo S, Abadie JV, Kaye AD. Perioperative Management of Neurofibromatosis Type 1. The Ochsner Journal. 2012;12(2):111-21.
- 2. Hirsch NP, Murphy A, Radcliffe JJ. Neurofibromatosis: Clinical presentations and anaesthetic implications. Br J Anaesth. 2001;86:555-64.
- 3. Spiegel R, Mächler M, Stocker HP, Boltshauser E, Schmid W. Neurofibromatosis Type 1: Genetic studies with DNA markers in 38 families. Schweiz Med Wochenschr. 1991;121:1445-52.
- 4. Lee WY, Shin YS, Lim CS, Chung WS, Kim BM: Spinal anesthesia for emergency cesarean section in a preeclampsia patient diagnosed with type 1 neurofibromatosis. Korean Journal of Anesthesiology. 2013;65(6):91-2.
- 5. Sakai T, Vallejo M, Shannon K. A parturient with neurofibromatosis type 2: anesthetic and obstetric considerations for delivery. International Journal of Obstetric Anesthesia. 2005;14(4):332-5.
- 6. Jouhilahti EM, Peltonen S, Heape AM, Peltonen J. The pathoetiology of neurofibromatosis 1.Am J Pathol. 2011;178:1932-9.
- 7. Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: A twenty first century perspective. Lancet Neurol. 2007;6:340-51.
- 8. Kanter WR, Eldridge R, Fabricant R, Allen JC, Koerber T. Central neurofibromatosis with bilateral acoustic neuroma: Genetic, clinical and biochemical distinctions from peripheral neurofibromatosis. Neurology. 1980;30:851-9.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Anesteziyoloji
Bölüm
Olgu Sunumu
Yazarlar
İrem Gümüş Özcan
0000-0001-5260-7945
Türkiye
Yayımlanma Tarihi
1 Mayıs 2022
Gönderilme Tarihi
31 Mart 2021
Kabul Tarihi
4 Mayıs 2022
Yayımlandığı Sayı
Yıl 1970 Cilt: 6 Sayı: 5
APA
Çetinkaya Ethemoğlu, F. B., & Gümüş Özcan, İ. (2022). Anesthesia management in a pregnant patient with neurofibromatosis. Journal of Surgery and Medicine, 6(5), 591-593. https://doi.org/10.28982/josam.907090
AMA
1.Çetinkaya Ethemoğlu FB, Gümüş Özcan İ. Anesthesia management in a pregnant patient with neurofibromatosis. J Surg Med. 2022;6(5):591-593. doi:10.28982/josam.907090
Chicago
Çetinkaya Ethemoğlu, Filiz Banu, ve İrem Gümüş Özcan. 2022. “Anesthesia management in a pregnant patient with neurofibromatosis”. Journal of Surgery and Medicine 6 (5): 591-93. https://doi.org/10.28982/josam.907090.
EndNote
Çetinkaya Ethemoğlu FB, Gümüş Özcan İ (01 Mayıs 2022) Anesthesia management in a pregnant patient with neurofibromatosis. Journal of Surgery and Medicine 6 5 591–593.
IEEE
[1]F. B. Çetinkaya Ethemoğlu ve İ. Gümüş Özcan, “Anesthesia management in a pregnant patient with neurofibromatosis”, J Surg Med, c. 6, sy 5, ss. 591–593, May. 2022, doi: 10.28982/josam.907090.
ISNAD
Çetinkaya Ethemoğlu, Filiz Banu - Gümüş Özcan, İrem. “Anesthesia management in a pregnant patient with neurofibromatosis”. Journal of Surgery and Medicine 6/5 (01 Mayıs 2022): 591-593. https://doi.org/10.28982/josam.907090.
JAMA
1.Çetinkaya Ethemoğlu FB, Gümüş Özcan İ. Anesthesia management in a pregnant patient with neurofibromatosis. J Surg Med. 2022;6:591–593.
MLA
Çetinkaya Ethemoğlu, Filiz Banu, ve İrem Gümüş Özcan. “Anesthesia management in a pregnant patient with neurofibromatosis”. Journal of Surgery and Medicine, c. 6, sy 5, Mayıs 2022, ss. 591-3, doi:10.28982/josam.907090.
Vancouver
1.Filiz Banu Çetinkaya Ethemoğlu, İrem Gümüş Özcan. Anesthesia management in a pregnant patient with neurofibromatosis. J Surg Med. 01 Mayıs 2022;6(5):591-3. doi:10.28982/josam.907090